Stock GNRO GENEURO SA
Add to a list
To use this feature you must be a member
Log inSign up

All News GeNeuro SA

Equities

GNRO

CH0308403085

Real-time Euronext Paris
Other stock markets
 15:06:37 29/04/2024 BST 		5-day change 1st Jan Change
1.46 EUR +2.10% Intraday chart for GeNeuro SA +1.74% +33.94%
03-20 Geneuro SA Announces Appointments of Board of Directors CI
02-02 GeNeuro: share price falls after private placement CF

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
GeNeuro Announces Approval of all Resolutions Proposed at March 18, 2024, Extraordinary General Meeting
BU
Geneuro SA Announces Appointments of Board of Directors
CI
GeNeuro: share price falls after private placement
CF
GeNeuro Raises EUR5 Million from Share Issue
MT
GeNeuro appoints new Chief Medical Officer
CF
Geneuro Sa Announces Executive Changes
CI
GeNeuro: Citigroup Global Markets Ltd crosses the 5% threshold
CF
GeNeuro - Independent Data Monitoring Committee recommends continuing the trial evaluating temelimab in Long COVID without any modifications
AQ
GeNeuro: positive opinion for continuation of trial
CF
GeNeuro's Mid-stage Study for Post-COVID Symptoms Therapy Gets Medical Committee's Nod
MT
Geneuro S.A. Recommends Continuing the Trial Evaluating Temelimab in Long Covid Without Modifications
CI
GeNeuro Finalizes Patient Enrollment in Early-stage Trial of Long-COVID Treatment
MT
GeNeuro: end of recruitment for Covid long trial
CF
GeNeuro Announces Completion of Recruitment of its Long-COVID Phase 2 Trial and Confirms Top-Line Results for June 2024
CI
GeNeuro : Investor Presentation October 2023
PU
GeNeuro and Verily Collaborate to Advance Long-COVID Research
CI
GeNeuro : Half yearly financial reports and audit reports/limited reviews / Half yearly financial report
PU
GeNeuro Reports 2023 Half-Year Results and Provides Corporate Update
AQ
GeNeuro SA Reports Earnings Results for the Half Year Ended June 30, 2023
CI
GeNeuro - New study published in PNAS further substantiates the neuropathogenic role of the HERV-W protein in MS
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GNRO Stock
  4. News GeNeuro SA